VSIR and melanoma: Furthermore, Choi et al. documented that VISTA is highly expressed in 27% of melanoma patients (37/136) and that high VISTA expression is correlated with advanced disease stage (p = 0.008) and inferior median OS (58.0 vs. 79.0 months, p = 0.017) [121].